|
LOCATION | CALL # | STATUS | MESSAGE |
---|---|---|---|
MUSKINGUM STACKS | RB155.8 .I58 2001 | AVAILABLE |
|
LOCATION | CALL # | STATUS | MESSAGE |
---|---|---|---|
MUSKINGUM STACKS | RB155.8 .I58 2001 | AVAILABLE |
|
Table of Contents | ||||||
---|---|---|---|---|---|---|
Preface | ||||||
Contributors | ||||||
Ch. 1 | Molecular Medicine and Gene Therapy: An Introduction / Thomas F. Kresina, Andrea D. Branch | 1 | ||||
Ch. 2 | Nuclear Transplantation and New Frontiers in Genetic Molecular Medicine / D. Joseph Jerry, James Robl, Leonard M. Fleck | 25 | ||||
Ch. 3 | Building a Better Mouse: Genetically Altered Mice as Models for Gane Therapy / Eric Sandgren, William C. Kisseberth | 47 | ||||
Ch. 4 | Vectors in Gene Therapy / Katherine Parker Ponder | 77 | ||||
Ch. 5 | Gene Targeting / Eric B. Kmiec | 113 | ||||
Ch. 6 | Gene Therapy for Hematological Disorders / Cynthia E. Dunbar, Tong Wu | 133 | ||||
Ch. 7 | Gene Therapy for Liver Disease / Christy L. Schilling, Martin J. Schuster, George Wu | 153 | ||||
Ch. 8 | Gene Therapy in Cardiovascular Disease / Victor J. Dzau, Afshin Ehsan, Michael J. Mann | 183 | ||||
Ch. 9 | Components of Cell and Gene Therapy for Neurological Disorders / Laurie C. Doering | 203 | ||||
Ch. 10 | Gene Therapy in the Treatment of Cancer [et al.] / Simon J. Hall, Thomas F. Kresina, Richard Trauger | 235 | ||||
Ch. 11 | Gene Therapy for HIV Infection / Bruce Bunnell | 263 | ||||
Ch. 12 | Gene Therapy Approaches for Rheumatoid Arthritis / Renate E. Gay, Steffen Gray, Thomas Pap | 291 | ||||
Ch. 13 | Federal Oversight of Gene Therapy Research / Thomas F. Kresina | 303 | ||||
Ch. 14 | Ethical Issues in Molecular Medicine and Gene Therapy / Leonard M. Fleck | 319 | ||||
Ch. 15 | Epilogue: Personal Genetic Medicine - The Future Is Now / Thomas F. Kresina | 347 | ||||
App | Commercial Implications: Large-Scale DNA Production and Quality Control; Technology Advancement and Elucidating the Human Genome / Charles Lollo, Andrea D. Branch | 353 | ||||
Index | 375 |
If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team